1. Home
  2. WFCF vs IFRX Comparison

WFCF vs IFRX Comparison

Compare WFCF & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

HOLD

Current Price

$12.83

Market Cap

59.1M

Sector

Technology

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.05

Market Cap

86.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
IFRX
Founded
1996
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
86.0M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
WFCF
IFRX
Price
$12.83
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
3.8K
1.4M
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
$73,729.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,075.42
P/E Ratio
$24.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$0.71
52 Week High
$13.78
$2.77

Technical Indicators

Market Signals
Indicator
WFCF
IFRX
Relative Strength Index (RSI) 54.45 41.24
Support Level $12.50 $1.04
Resistance Level $13.43 $1.12
Average True Range (ATR) 0.43 0.09
MACD 0.09 -0.01
Stochastic Oscillator 72.73 33.31

Price Performance

Historical Comparison
WFCF
IFRX

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: